> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Outsourcing Facility Challenges
- URL: https://www.fdaweb.com/info-collection-on-outsourcing-facility-challenges/
- Published: 2020-06-17T12:00:00.000Z
- Updated: 2026-09-14T16:18:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147027

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Obtaining Information to Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities” (OMB Control Number0910-0883). FDA intends to conduct research to understand better the challenges and opportunities encountered by the outsourcing facility sector in a number of different areas. These include: operational barriers and opportunities related to the outsourcing facility market and business viability; knowledge and operational barriers and opportunities related to compliance with federal policies and good quality drug production; and barriers and opportunities related to outsourcing facility interactions with FDA. The results of the research will be used by FDA to develop a comprehensive understanding of the outsourcing facility sector, its challenges, and opportunities for advancement. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2020-13086.pdf?ref=fdaweb.com).